These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28736961)

  • 1. Changes in cytokine profiles following treatment with food allergen-specific sublingual immunotherapy in dogs with adverse food reactions.
    Maina E; Devriendt B; Cox E
    Vet Dermatol; 2017 Dec; 28(6):612-e149. PubMed ID: 28736961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double blind, randomized, placebo controlled trial of the efficacy, quality of life and safety of food allergen-specific sublingual immunotherapy in client owned dogs with adverse food reactions: a small pilot study.
    Maina E; Cox E
    Vet Dermatol; 2016 Oct; 27(5):361-e91. PubMed ID: 27426929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food allergen-specific sublingual immunotherapy modulates peripheral T cell responses of dogs with adverse food reactions.
    Maina E; Devriendt B; Cox E
    Vet Immunol Immunopathol; 2019 Jun; 212():38-42. PubMed ID: 31213250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
    Savolainen J; Jacobsen L; Valovirta E
    Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study.
    Mueller RS; Veir J; Fieseler KV; Dow SW
    Vet Dermatol; 2005 Feb; 16(1):61-8. PubMed ID: 15725107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome and IL-17, IL-23, IL-27 and FOXP3 expression in peripheral blood mononuclear cells of pollen-allergic children during sublingual immunotherapy.
    Nieminen K; Valovirta E; Savolainen J
    Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e174-84. PubMed ID: 19566585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy.
    Keppel KE; Campbell KL; Zuckermann FA; Greeley EA; Schaeffer DJ; Husmann RJ
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):337-44. PubMed ID: 18423890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
    Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
    J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
    Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
    Sakashita M; Yamada T; Imoto Y; Hirota T; Tamari M; Ito Y; Kubo S; Osawa Y; Takahashi N; Fujieda S
    Cytokine; 2015 Sep; 75(1):181-5. PubMed ID: 25934649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Food-specific sublingual immunotherapy is well tolerated and safe in healthy dogs: a blind, randomized, placebo-controlled study.
    Maina E; Pelst M; Hesta M; Cox E
    BMC Vet Res; 2017 Jan; 13(1):25. PubMed ID: 28100257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specific immunotherapy using allergens apropos of specific immunotherapy by the sublingual route].
    Sabbah A
    Allerg Immunol (Paris); 1998 Sep; 30(7):221-8. PubMed ID: 9823421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate and lymphocytic response of birch-allergic patients before and after sublingual immunotherapy.
    Guida G; Boita M; Scirelli T; Bommarito L; Heffler E; Badiu I; Bellone G; Mietta S; Mistrello G; Rolla G
    Allergy Asthma Proc; 2012; 33(5):411-5. PubMed ID: 22762741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy.
    Bonvalet M; Moussu H; Wambre E; Ricarte C; Horiot S; Rimaniol AC; Kwok WW; Horak F; de Beaumont O; Baron-Bodo V; Moingeon P
    Clin Exp Allergy; 2012 Dec; 42(12):1745-55. PubMed ID: 23181790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.
    Burastero SE; Mistrello G; Falagiani P; Paolucci C; Breda D; Roncarolo D; Zanotta S; Monasterolo G; Rossi RE
    Ann Allergy Asthma Immunol; 2008 Apr; 100(4):343-50. PubMed ID: 18450120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
    Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
    J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen-specific immunotherapy induces Th1 shift in dogs with atopic dermatitis.
    Shida M; Kadoya M; Park SJ; Nishifuji K; Momoi Y; Iwasaki T
    Vet Immunol Immunopathol; 2004 Nov; 102(1-2):19-31. PubMed ID: 15451612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food allergen-specific serum IgG and IgE before and after elimination diets in allergic dogs.
    Zimmer A; Bexley J; Halliwell RE; Mueller RS
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):442-7. PubMed ID: 21955446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy.
    Savolainen J; Nieminen K; Laaksonen K; Laiho T; Jacobsen L; Lahesmaa R; Terho EO; Valovirta E
    Allergy; 2007 Aug; 62(8):949-53. PubMed ID: 17620074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early cytokine modulation after the rapid induction phase of sublingual immunotherapy with mite monomeric allergoids.
    Di Gioacchino M; Perrone A; Petrarca C; Di Claudio F; Mistrello G; Falagiani P; Dadorante V; Verna N; Braga M; Ballone E; Cavallucci E
    Int J Immunopathol Pharmacol; 2008; 21(4):969-76. PubMed ID: 19144282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.